<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35552466</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-0407</ISSN><JournalIssue CitedMedium="Internet"><Volume>93</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Der Nervenarzt</Title><ISOAbbreviation>Nervenarzt</ISOAbbreviation></Journal><ArticleTitle>[Manifestations of the central nervous system after COVID-19].</ArticleTitle><Pagination><StartPage>769</StartPage><EndPage>778</EndPage><MedlinePgn>769-778</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00115-022-01294-2</ELocationID><Abstract><AbstractText>Numerous diseases of the central nervous system (CNS), especially in the postacute phase after an infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been described. These include neuroimmunologically mediated diseases, such as encephalopathy, encephalitis, myelitis, acute disseminated encephalomyelitis (ADEM), acute necrotizing hemorrhagic leukoencephalitis (ANHLE) and neuromyelitis optica spectrum disorder (NMOSD) as well as others, such as posterior reversible encephalopathy syndrome (PRES), opsoclonus myoclonus ataxia (OMA) and cerebrovascular diseases. A parainfectious or postinfectious association is discussed but the pathophysiological mechanisms are so far unknown. Underlying mechanisms could be a virus-triggered overactivation of the immune system with hyperinflammation and cytokine storm but possibly also the development of specific autoantibodies against CNS tissue. Direct damage due to the invasion of SARS-CoV&#x2011;2 into the brain or spinal cord does not seem to play a relevant role. An exact clinical phenotyping and initiation of additional diagnostics are recommended, also to rule out other causes. To date no medicinal treatment options for CNS manifestations of long COVID exist; however, first results regarding inflammation and autoimmunity are promising and could lead to new treatment approaches.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gerhard</LastName><ForeName>Ameli</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Neurologie und Experimentelle Neurologie, Charit&#xe9;&#xa0;- Universit&#xe4;tsmedizin Berlin, Hindenburgdamm&#xa0;30, 12200, Berlin, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pr&#xfc;&#xdf;</LastName><ForeName>Harald</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Neurologie und Experimentelle Neurologie, Charit&#xe9;&#xa0;- Universit&#xe4;tsmedizin Berlin, Hindenburgdamm&#xa0;30, 12200, Berlin, Deutschland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Deutsches Zentrum f&#xfc;r Neurodegenerative Erkrankungen (DZNE) Berlin, Berlin, Deutschland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franke</LastName><ForeName>Christiana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Klinik f&#xfc;r Neurologie und Experimentelle Neurologie, Charit&#xe9;&#xa0;- Universit&#xe4;tsmedizin Berlin, Hindenburgdamm&#xa0;30, 12200, Berlin, Deutschland. christiana.franke@charite.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Manifestationen im Zentralnervensystem nach COVID-19.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Nervenarzt</MedlineTA><NlmUniqueID>0400773</NlmUniqueID><ISSNLinking>0028-2804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009422" MajorTopicYN="Y">Nervous System Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054038" MajorTopicYN="Y">Posterior Leukoencephalopathy Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="ger"><AbstractText>Zahlreiche Erkrankungen des Zentralnervensystems sind insbesondere in der Postakutphase nach einer Infektion mit SARS-CoV&#x2011;2 (&#x201e;severe acute respiratory syndrome coronavirus&#xa0;2&#x201c;) beschrieben. Diese umfassen neuroimmunologisch vermittelte Erkrankungen wie Enzephalopathien, Enzephalitiden, Myelitiden, ADEM (akute disseminierte Enzephalomyelitis), ANHLE (akute nekrotisierende h&#xe4;morrhagische Leukoenzephalitis) und NMOSD (Neuromyelitis-optica-Spektrum-Erkrankungen), aber auch andere wie PRES (posteriores reversibles Enzephalopathiesyndrom), OMAS (Opsoklonus-Myoklonus-Ataxie-Syndrom) sowie zerebrovaskul&#xe4;re Erkrankungen. Ein para- oder postinfekti&#xf6;ser Zusammenhang wird diskutiert, jedoch sind pathophysiologische Mechanismen bislang unbekannt. Urs&#xe4;chlich k&#xf6;nnte eine virusgetriggerte &#xdc;beraktivierung des Immunsystems mit Hyperinflammation und Zytokinsturm, aber m&#xf6;glicherweise auch die Bildung spezifischer Autoantik&#xf6;rper gegen Gewebe des Zentralnervensystems sein. Eine direkte Sch&#xe4;digung durch die Invasion von SARS-CoV&#x2011;2 in das Gehirn oder das R&#xfc;ckenmark scheint keine relevante Rolle zu spielen. Eine exakte klinische Ph&#xe4;notypisierung und Einleitung von Zusatzdiagnostik, auch zum Ausschluss anderer Ursachen, ist empfohlen. Bislang existieren noch keine medikament&#xf6;sen Therapieoptionen zur Behandlung von ZNS-Manifestationen beim Long-COVID(&#x201e;coronavirus disease&#x201c;)-Syndrom. Erste Befunde zu Inflammation und Autoimmunit&#xe4;t sind jedoch vielversprechend und k&#xf6;nnten zu neuen Therapieans&#xe4;tzen f&#xfc;hren.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoantibodies</Keyword><Keyword MajorTopicYN="N">Encephalitis</Keyword><Keyword MajorTopicYN="N">Hyperinflammation</Keyword><Keyword MajorTopicYN="N">Immunotherapy</Keyword><Keyword MajorTopicYN="N">Myelitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>13</Day><Hour>14</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35552466</ArticleId><ArticleId IdType="pmc">PMC9096778</ArticleId><ArticleId IdType="doi">10.1007/s00115-022-01294-2</ArticleId><ArticleId IdType="pii">10.1007/s00115-022-01294-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ahmad SA, Kakamad FH, Mohamad HS, et al. Post COVID-19 cerebral venous sinus thrombosis; a&#xa0;case report. Ann Med Surg. 2021;72:103031. doi: 10.1016/j.amsu.2021.103031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.103031</ArticleId><ArticleId IdType="pmc">PMC8578025</ArticleId><ArticleId IdType="pubmed">34777797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad SA, Salih KH, Ahmed SF, et al. Post COVID-19 transverse myelitis; a&#xa0;case report with review of literature. Ann Med Surg. 2021;69:102749. doi: 10.1016/j.amsu.2021.102749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102749</ArticleId><ArticleId IdType="pmc">PMC8380545</ArticleId><ArticleId IdType="pubmed">34457267</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson RC, Patel V, Sheikh-Bahaei N, et al. Posterior reversible encephalopathy syndrome (PRES): pathophysiology and neuro-imaging. Front Neurol. 2020;11:463. doi: 10.3389/fneur.2020.00463.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00463</ArticleId><ArticleId IdType="pmc">PMC7308488</ArticleId><ArticleId IdType="pubmed">32612567</ArticleId></ArticleIdList></Reference><Reference><Citation>Asan L, Klebe S, Kleinschnitz C, et al. Anti-GFAP-antibody positive postinfectious acute cerebellar ataxia and myoclonus after COVID-19: a&#xa0;case report. Ther Adv Neurol Disord. 2021;14:17562864211062824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8664296</ArticleId><ArticleId IdType="pubmed">34899988</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis. Eur J Neurol. 2021;28:3478&#x2013;3490. doi: 10.1111/ene.14727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14727</ArticleId><ArticleId IdType="pmc">PMC8014715</ArticleId><ArticleId IdType="pubmed">33426733</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltaziak K, Szpringer A, Czarnek-Chudzik A, et al. Quadrantanopia as the only symptom of post-COVID stroke in the occipital pole: case report. Medicine. 2021;100:e27542. doi: 10.1097/MD.0000000000027542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000027542</ArticleId><ArticleId IdType="pmc">PMC8568388</ArticleId><ArticleId IdType="pubmed">34871216</ArticleId></ArticleIdList></Reference><Reference><Citation>Beauchamp LC, Finkelstein DI, Bush AI, et al. Parkinsonism as a&#xa0;third wave of the COVID-19 pandemic? J Parkinsons Dis. 2020;10:1343&#x2013;1353. doi: 10.3233/JPD-202211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202211</ArticleId><ArticleId IdType="pmc">PMC7683045</ArticleId><ArticleId IdType="pubmed">32986683</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlit P, B&#xf6;sel J, Franke C et&#xa0;al. (2021) Neurologische Manifestationen, S1-Leitlinie. In: Deutsche Gesellschaft f&#xfc;r Neurologie (Hrsg.), Leitlinien f&#xfc;r Diagnostik und Therapie in der Neurologie. Online: www.dgn.org/leitlinien (abgerufen am 5. Apr. 2022)</Citation></Reference><Reference><Citation>Bertin D, Kaphan E, Weber S, et al. Persistent IgG anticardiolipin autoantibodies are associated with post-COVID syndrome. Int J Infect Dis. 2021;113:23&#x2013;25. doi: 10.1016/j.ijid.2021.09.079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.079</ArticleId><ArticleId IdType="pmc">PMC8487460</ArticleId><ArticleId IdType="pubmed">34614444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296&#x2013;301. doi: 10.1126/science.abj8222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abj8222</ArticleId><ArticleId IdType="pubmed">35025605</ArticleId></ArticleIdList></Reference><Reference><Citation>Boesl F, Audebert H, Endres M, et al. A neurological outpatient clinic for patients with post-COVID-19 syndrome&#x2014;a report on the clinical presentations of the first 100 patients. Front Neurol. 2021;12:738405. doi: 10.3389/fneur.2021.738405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.738405</ArticleId><ArticleId IdType="pmc">PMC8481602</ArticleId><ArticleId IdType="pubmed">34603189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2021;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang HH, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020;26:1636&#x2013;1643. doi: 10.1038/s41591-020-1051-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dono F, Carrarini C, Russo M, et al. New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a&#xa0;case report. Neurol Sci. 2021;42:35&#x2013;38. doi: 10.1007/s10072-020-04846-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04846-z</ArticleId><ArticleId IdType="pmc">PMC7608104</ArticleId><ArticleId IdType="pubmed">33145624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey D, Pittock SJ, Kelly CR, et al. Autoimmune encephalitis epidemiology and a&#xa0;comparison to infectious encephalitis. Ann Neurol. 2018;83:166&#x2013;177. doi: 10.1002/ana.25131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25131</ArticleId><ArticleId IdType="pmc">PMC6011827</ArticleId><ArticleId IdType="pubmed">29293273</ArticleId></ArticleIdList></Reference><Reference><Citation>Emamikhah M, Babadi M, Mehrabani M, et al. Opsoclonus-myoclonus syndrome, a&#xa0;post-infectious neurologic complication of COVID-19: case series and review of literature. J Neurovirol. 2021;27:26&#x2013;34. doi: 10.1007/s13365-020-00941-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00941-1</ArticleId><ArticleId IdType="pmc">PMC7831695</ArticleId><ArticleId IdType="pubmed">33492608</ArticleId></ArticleIdList></Reference><Reference><Citation>Emekli AS, Parlak A, G&#xf6;cen NY, et al. Anti-GAD associated post-infectious cerebellitis after COVID-19 infection. Neurol Sci. 2021;42:3995&#x2013;4002. doi: 10.1007/s10072-021-05506-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05506-6</ArticleId><ArticleId IdType="pmc">PMC8322110</ArticleId><ArticleId IdType="pubmed">34328578</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. The presence of headache at onset in SARS-coV-2 infection is associated with long-term post-COVID headache and fatigue: a case-control study. Cephalalgia. 2021;41:1332&#x2013;1341. doi: 10.1177/03331024211020404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024211020404</ArticleId><ArticleId IdType="pmc">PMC8212025</ArticleId><ArticleId IdType="pubmed">34134526</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke&#xa0;C et&#xa0;al (2022) Association of cerebrospinal fluid autoantibodies with cognitive impairment in post-COVID-19 syndrome (currently under revision)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19&#xa0;patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2013;419. doi: 10.1016/j.bbi.2020.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg . Long-COVID-Medikament: Hilfe f&#xfc;r weitere Betroffene. Website der Friedrich-Alexander-Universit&#xe4;t Erlangen-N&#xfc;rnberg; 2021.</Citation></Reference><Reference><Citation>Fukushima EFA, Nasser A, Bhargava A, et al. Post-infectious focal encephalitis due to COVID-19. Germs. 2021;11:111&#x2013;115. doi: 10.18683/germs.2021.1247.</Citation><ArticleIdList><ArticleId IdType="doi">10.18683/germs.2021.1247</ArticleId><ArticleId IdType="pmc">PMC8057841</ArticleId><ArticleId IdType="pubmed">33898348</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelibter S, Bellavia G, Arbasino C, Arn&#xf2; N, Glorioso M, Mazza S, Murelli R, Sciarretta M, Dallocchio C. Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19. J&#xa0;Neurol. 2022;269(5):2293&#x2013;2300. doi: 10.1007/s00415-021-10947-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10947-2</ArticleId><ArticleId IdType="pmc">PMC8721625</ArticleId><ArticleId IdType="pubmed">34978621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh R, De K, Roy D, et al. A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection. J Neuroimmunol. 2020;350:577439. doi: 10.1016/j.jneuroim.2020.577439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2020.577439</ArticleId><ArticleId IdType="pmc">PMC7657006</ArticleId><ArticleId IdType="pubmed">33333471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardhana C, Nanayakkara G, Gamage D, et al. Delayed presentation of postinfectious encephalitis associated with SARS-CoV-2 infection: a&#xa0;case report. Neurol Sci. 2021;42:3527&#x2013;3530. doi: 10.1007/s10072-021-05395-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05395-9</ArticleId><ArticleId IdType="pmc">PMC8209772</ArticleId><ArticleId IdType="pubmed">34138387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara M, Kouda K, Mizoguchi T, et al. COVID-19 post-infectious encephalitis presenting with delirium as an initial manifestation. J Investig Med High Impact Case Rep. 2021;9:23247096211029787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8267028</ArticleId><ArticleId IdType="pubmed">34229469</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman LA, Vilensky JA. Encephalitis lethargica: 100&#xa0;years after the epidemic. Brain. 2017;140:2246&#x2013;2251. doi: 10.1093/brain/awx177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx177</ArticleId><ArticleId IdType="pubmed">28899018</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Ganslmayer M, Lucio M, et al. Retinal microcirculation as a&#xa0;correlate of a&#xa0;systemic capillary impairment after severe acute respiratory syndrome Coronavirus 2 infection. Front Med. 2021;8:676554. doi: 10.3389/fmed.2021.676554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.676554</ArticleId><ArticleId IdType="pmc">PMC8299003</ArticleId><ArticleId IdType="pubmed">34307408</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohberger B, Harrer T, Mardin C, et al. Case report: neutralization of autoantibodies targeting G-protein-coupled receptors improves capillary impairment and fatigue symptoms after COVID-19 infection. Front Med. 2021;8:754667. doi: 10.3389/fmed.2021.754667.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.754667</ArticleId><ArticleId IdType="pmc">PMC8637609</ArticleId><ArticleId IdType="pubmed">34869451</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo&#xa0;S, Ferse&#xa0;C, Boesl&#xa0;F et&#xa0;al (2022) Intravenous immunoglobulins for treatment of severe COVID-19 related acute encephalopathy. J&#xa0;Neurol (accepted for publication)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9089297</ArticleId><ArticleId IdType="pubmed">35538168</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27.e11. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeanneret V, Winkel D, Risman A, et al. Post-infectious rhombencephalitis after coronavirus-19 infection: a case report and literature review. J Neuroimmunol. 2021;357:577623. doi: 10.1016/j.jneuroim.2021.577623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577623</ArticleId><ArticleId IdType="pmc">PMC8164357</ArticleId><ArticleId IdType="pubmed">34082192</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentzer A, Carra-Dalli&#xe8;re C, Lozano C, Riviere S, Darmon O, Ayrignac X, Labauge P, Vincent T. Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies. J. Neurol. 2022 doi: 10.1007/s00415-022-10972-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-10972-9</ArticleId><ArticleId IdType="pmc">PMC8783181</ArticleId><ArticleId IdType="pubmed">35064812</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesuthasan A, Massey F, Manji H, et al. Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19. J Neurol Sci. 2021;428:117608. doi: 10.1016/j.jns.2021.117608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117608</ArticleId><ArticleId IdType="pmc">PMC8332920</ArticleId><ArticleId IdType="pubmed">34391037</ArticleId></ArticleIdList></Reference><Reference><Citation>Jozuka R, Kimura H, Uematsu T, Fujigaki H, Yamamoto Y, Kobayashi M, Kawabata K, Koike H, Inada T, Saito K, Katsuno M, Ozaki N. Severe and long-lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID-19: A case report. Neuropsychopharmacol Rep. 2022;42(1):114&#x2013;119. doi: 10.1002/npr2.12222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/npr2.12222</ArticleId><ArticleId IdType="pmc">PMC8919122</ArticleId><ArticleId IdType="pubmed">34889531</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya Y, Kara S, Akinci C, et al. Transient cortical blindness in COVID-19 pneumonia; a&#xa0;PRES-like syndrome: case report. J Neurol Sci. 2020;413:116858. doi: 10.1016/j.jns.2020.116858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.116858</ArticleId><ArticleId IdType="pmc">PMC7187859</ArticleId><ArticleId IdType="pubmed">32387762</ArticleId></ArticleIdList></Reference><Reference><Citation>Kincaid O, Lipton HL. Viral myelitis: an update. Curr Neurol Neurosci Rep. 2006;6:469&#x2013;474. doi: 10.1007/s11910-006-0048-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-006-0048-1</ArticleId><ArticleId IdType="pubmed">17074281</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaas JP, Ahlskog JE, Pittock SJ, et al. Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012;69:1598&#x2013;1607. doi: 10.1001/archneurol.2012.1173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2012.1173</ArticleId><ArticleId IdType="pubmed">22986354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleineberg NN, Knauss S, G&#xfc;lke E, et al. Neurological symptoms and complications in predominantly hospitalized COVID-19&#xa0;patients: results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS) Eur J Neurol. 2021;28:3925&#x2013;3937. doi: 10.1111/ene.15072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15072</ArticleId><ArticleId IdType="pmc">PMC8444823</ArticleId><ArticleId IdType="pubmed">34411383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobaidze K, Shin YM, Japaridze M, Karakis I, Wu X. Posterior Reversible Leukoencephalopathy Syndrome in a Patient after Acute COVID-19 Infection. Case Rep Neurol Med. 2021 doi: 10.1155/2021/5564802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5564802</ArticleId><ArticleId IdType="pmc">PMC8096577</ArticleId><ArticleId IdType="pubmed">33996162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Alberola R, Georgiou M, Sfakianakis GN, et al. Contemporary Encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes. J Neurol. 2009;256:396&#x2013;404. doi: 10.1007/s00415-009-0074-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-0074-4</ArticleId><ArticleId IdType="pubmed">19412724</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a&#xa0;systematic review and meta-analysis. Sci Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021;8(6):e1080. doi: 10.1212/NXI.0000000000001080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001080</ArticleId><ArticleId IdType="pmc">PMC8404207</ArticleId><ArticleId IdType="pubmed">34452974</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuccio FG, Barra M, Claudio G, et al. A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection. J Neurol. 2021;268:2327&#x2013;2330. doi: 10.1007/s00415-020-10219-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10219-5</ArticleId><ArticleId IdType="pmc">PMC7497229</ArticleId><ArticleId IdType="pubmed">32940797</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a&#xa0;post-mortem case series. Lancet Neurol. 2020;19:919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, et al. Association of self-reported COVID-19 infection and SARS-coV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182:19&#x2013;25. doi: 10.1001/jamainternmed.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a&#xa0;port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel-Ch&#xe1;vez A, Garc&#xed;a-Grimshaw M, Ch&#xe1;vez-Mart&#xed;nez OA, Cant&#xfa;-Brito C, Romero-S&#xe1;nchez GT, Flores-Silva FD, Merayo-Chalico FJ, Mart&#xed;nez-Carrillo FM, Barrera-Vargas A, Vald&#xe9;s-Ferrer SI. Posterior reversible encephalopathy syndrome during convalescence from COVID-19. Int J Neurosci. 2021 doi: 10.1080/00207454.2021.1966629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2021.1966629</ArticleId><ArticleId IdType="pubmed">34370958</ArticleId></ArticleIdList></Reference><Reference><Citation>Morassi M, Palmerini F, Nici S, et al. SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients. J Neurol. 2021;268:3980&#x2013;3987. doi: 10.1007/s00415-021-10560-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10560-3</ArticleId><ArticleId IdType="pmc">PMC8059684</ArticleId><ArticleId IdType="pubmed">33884450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni S, De Groot R, Bell S, et al. Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke. 2021;16:137&#x2013;149. doi: 10.1177/1747493020972922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020972922</ArticleId><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Nice&#xa0;R (publishing) Sign COVID-19 rapid guideline: managing the long-term effects of COVID-19. Version history and subscription 1.14 published on 01.03.2022</Citation></Reference><Reference><Citation>Oh SY, Kim JS, Dieterich M. Update on opsoclonus-myoclonus syndrome in adults. J Neurol. 2019;266:1541&#x2013;1548. doi: 10.1007/s00415-018-9138-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-9138-7</ArticleId><ArticleId IdType="pubmed">30483882</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2013;369(14):1306&#x2013;1316. doi: 10.1056/NEJMoa1301372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301372</ArticleId><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Payus AO, Jeffree MS, Ohn MH, Tan HJ, Ibrahim A, Chia YK, Raymond AA. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Neurol Sci. 2022;43(3):1533&#x2013;1547. doi: 10.1007/s10072-021-05785-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05785-z</ArticleId><ArticleId IdType="pmc">PMC8635316</ArticleId><ArticleId IdType="pubmed">34853897</ArticleId></ArticleIdList></Reference><Reference><Citation>Picod A, Dinkelacker V, Savatovsky J, et al. SARS-CoV-2-associated encephalitis: arguments for a&#xa0;post-infectious mechanism. Crit Care. 2020;24:658. doi: 10.1186/s13054-020-03389-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03389-1</ArticleId><ArticleId IdType="pmc">PMC7682681</ArticleId><ArticleId IdType="pubmed">33228760</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinzon RT, Kumalasari MD, Kristina H. Ischemic Stroke following COVID-19 in a Patient without Comorbidities. Case Rep Med. 2021 doi: 10.1155/2021/8178529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8178529</ArticleId><ArticleId IdType="pmc">PMC8575649</ArticleId><ArticleId IdType="pubmed">34759970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzanelli C, Milano C, Canovetti S, et al. Autoimmune limbic encephalitis related to SARS-coV-2 infection: case-report and review of the literature. Brain Behav Immun Health. 2021;12:100210. doi: 10.1016/j.bbih.2021.100210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100210</ArticleId><ArticleId IdType="pmc">PMC7830195</ArticleId><ArticleId IdType="pubmed">33521691</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl D, Alper G, Van Haren K, et al. Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology. 2016;87:S38&#x2013;S45. doi: 10.1212/WNL.0000000000002825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002825</ArticleId><ArticleId IdType="pubmed">27572859</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Princiotta Cariddi L, Tabaee Damavandi P, Carimati F, et al. Reversible Encephalopathy Syndrome (PRES) in a&#xa0;COVID-19&#xa0;patient. J Neurol. 2020;267:3157&#x2013;3160. doi: 10.1007/s00415-020-10001-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10001-7</ArticleId><ArticleId IdType="pmc">PMC7312113</ArticleId><ArticleId IdType="pubmed">32583053</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xfc;ss H. Postviral autoimmune encephalitis: manifestations in children and adults. Curr Opin Neurol. 2017;30:327&#x2013;333. doi: 10.1097/WCO.0000000000000445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000445</ArticleId><ArticleId IdType="pubmed">28234798</ArticleId></ArticleIdList></Reference><Reference><Citation>Przytu&#x142;a F, B&#x142;&#x105;dek S, S&#x142;awek J. Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome. Neurol Neurochir Pol. 2021;55:310&#x2013;313. doi: 10.5603/PJNNS.a2021.0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/PJNNS.a2021.0036</ArticleId><ArticleId IdType="pubmed">34096013</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan S, Khunti K, Alwan N, et al. European Observatory Policy Briefs. European Observatory on Health Systems and Policies. Copenhagen: World Health Organization; 2021. In the wake of the pandemic: preparing for long COVID.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877759</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran I, Natarajan MD, Narwani P, et al. A case of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) presenting as post-infectious manifestation of SARS-CoV-2 infection. BJR Case Rep. 2021;7:20210020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8171128</ArticleId><ArticleId IdType="pubmed">34131509</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan C, Fusinski SD, Obeid IM, et al. Therapeutic plasma exchange for persistent encephalopathy associated with Covid-19. eNeurologicalSci. 2021;22:100327. doi: 10.1016/j.ensci.2021.100327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2021.100327</ArticleId><ArticleId IdType="pmc">PMC7868106</ArticleId><ArticleId IdType="pubmed">33585705</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad T, Golestani F. Cerebral venous sinus thrombosis after resolution of COVID-19 in a non-hospitalised patient. Postgrad Med J. 2021 doi: 10.1136/postgradmedj-2021-140693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/postgradmedj-2021-140693</ArticleId><ArticleId IdType="pubmed">37066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Safarpour Lima B, Mohammadi Khorasani N, Aghamiri SH, et al. Neurological complications of COVID-19: a rare case of bilateral blindness. J Emerg Med. 2021;61:e160&#x2013;e163. doi: 10.1016/j.jemermed.2021.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2021.07.035</ArticleId><ArticleId IdType="pmc">PMC8286872</ArticleId><ArticleId IdType="pubmed">34518048</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M, Sali&#xe9; H, Tanevski J, et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54:1594&#x2013;1610.e1511. doi: 10.1016/j.immuni.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Goereci Y, Franke C, Silling S, B&#xf6;sl F, Maier F, Heger E, Deiman B, Pr&#xfc;ss H, Onur OA, Klein F, Fink GR, Di Cristanziano V, Warnke C. Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection. Ann Neurol. 2022;91(1):150&#x2013;157. doi: 10.1002/ana.26262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Kleineberg NN, G&#xf6;reci Y, et al. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis. Curr Opin Neurol. 2021;34:423&#x2013;431. doi: 10.1097/WCO.0000000000000930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000930</ArticleId><ArticleId IdType="pubmed">33709973</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, et al. Persistent Symptoms in Adult Patients 1&#xa0;Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin Infect Dis. 2022;74(7):1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barr&#xe9; syndrome. Lancet. 2021;397:1214&#x2013;1228. doi: 10.1016/S0140-6736(21)00517-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00517-1</ArticleId><ArticleId IdType="pubmed">33647239</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepmann T, Sedghi A, Simon E, et al. Increased risk of acute stroke among patients with severe COVID-19: a&#xa0;multicenter study and meta-analysis. Eur J Neurol. 2021;28:238&#x2013;247. doi: 10.1111/ene.14535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14535</ArticleId><ArticleId IdType="pubmed">32920964</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadez-Calderon J, Ordinola Navarro A, Rodriguez-Chavez E, Vera-Lastra O. Co-expression of anti-NMDAR and anti-GAD65 antibodies. A case of autoimmune encephalitis in a post-COVID-19 patient [published online ahead of print, 2021 Oct 13] Neurologia. 2021 doi: 10.1016/j.nrl.2021.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nrl.2021.09.003</ArticleId><ArticleId IdType="pmc">PMC8556136</ArticleId><ArticleId IdType="pubmed">34744237</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>https://dgn.org/wp-content/uploads/2020/08/030144_LL_Neurologische_Manifestationen_bei_COVID-19_V3.1.pdf. Zugegriffen: 01.05.2022</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>